Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.

Buti S;Bersanelli M;Perrone F;Tiseo M;Tucci M;Adamo V;Stucci LS;Russo A;Tanda ET;Spagnolo F;Rastelli F;Pergolesi F;Santini D;Russano M;Anesi C;Giusti R;Filetti M;Marchetti P;Botticelli A;Gelibter A;Occhipinti MA;Ferrari M;Vitale MG;Nicolardi L;Chiari R;Rijavec E;Nigro O;Tuzi A;De Tursi M;Di Marino P;Conforti F;Queirolo P;Bracarda S;Macrini S;Gori S;Zoratto F;Veltri E;Di Cocco B;Mallardo D;Vitale MG;Santoni M;Patruno L;Porzio G;Ficorella C;Pinato DJ;Ascierto PA;Cortellini A

2021-01-01